Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

E-cadherin-dependent transcriptional control of apolipoprotein A-IV gene expression in intestinal epithelial cells: a role for the hepatic nuclear factor 4.

Peignon G, Thenet S, Schreider C, Fouquet S, Ribeiro A, Dussaulx E, Chambaz J, Cardot P, Pinçon-Raymond M, Le Beyec J.

J Biol Chem. 2006 Feb 10;281(6):3560-8. Epub 2005 Dec 7.

2.

Reg IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas.

Violette S, Festor E, Pandrea-Vasile I, Mitchell V, Adida C, Dussaulx E, Lacorte JM, Chambaz J, Lacasa M, Lesuffleur T.

Int J Cancer. 2003 Jan 10;103(2):185-93.

3.

Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status.

Violette S, Poulain L, Dussaulx E, Pepin D, Faussat AM, Chambaz J, Lacorte JM, Staedel C, Lesuffleur T.

Int J Cancer. 2002 Apr 1;98(4):498-504.

4.

Postmitotic differentiation of colon carcinoma caco-2 cells does not prevent reentry in the cell cycle and tumorigenicity.

Pandrea IV, Carrière V, Barbat A, Cambier D, Dussaulx E, Lesuffleur T, Rousset M, Zweibaum A.

Exp Mol Pathol. 2000 Aug;69(1):37-45.

PMID:
10891291
5.

Decreased expression of gamma-glutamyltranspeptidase in the intestinal cell line Caco-2 by inducers of cytochrome P450 1A1.

Carrière V, Dussaulx E, Rousset M, Zweibaum A, Cambier D.

Biochem Pharmacol. 1998 Oct 1;56(7):817-23.

PMID:
9774143
6.

Resistance to high concentrations of methotrexate and 5-fluorouracil of differentiated HT-29 colon-cancer cells is restricted to cells of enterocytic phenotype.

Lesuffleur T, Violette S, Vasile-Pandrea I, Dussaulx E, Barbat A, Muleris M, Zweibaum A.

Int J Cancer. 1998 May 4;76(3):383-92.

7.

Regulation of sucrase-isomaltase and hexose transporters in Caco-2 cells: a role for cytochrome P-4501A1?

Carrière V, Barbat A, Rousset M, Brot-Laroche E, Dussaulx E, Cambier D, De Waziers ID, Beaune P, Zweibaum A.

Am J Physiol. 1996 Jun;270(6 Pt 1):G976-86.

PMID:
8764205
8.

Modifications of the anti-oxidant metabolism during proliferation and differentiation of colon tumor cell lines.

Bravard A, Beaumatin J, Dussaulx E, Lesuffleur T, Zweibaum A, Luccioni C.

Int J Cancer. 1994 Dec 15;59(6):843-7.

PMID:
7989127
9.

Expression of cytochrome P-450 3A in HT29-MTX cells and Caco-2 clone TC7.

Carrière V, Lesuffleur T, Barbat A, Rousset M, Dussaulx E, Costet P, de Waziers I, Beaune P, Zweibaum A.

FEBS Lett. 1994 Dec 5;355(3):247-50. Erratum in: FEBS Lett 1995 Mar 27;362(1):99.

10.

Regulation of expression of the human fructose transporter (GLUT5) by cyclic AMP.

Mahraoui L, Takeda J, Mesonero J, Chantret I, Dussaulx E, Bell GI, Brot-Laroche E.

Biochem J. 1994 Jul 1;301 ( Pt 1):169-75.

11.

Presence and differential expression of SGLT1, GLUT1, GLUT2, GLUT3 and GLUT5 hexose-transporter mRNAs in Caco-2 cell clones in relation to cell growth and glucose consumption.

Mahraoui L, Rodolosse A, Barbat A, Dussaulx E, Zweibaum A, Rousset M, Brot-Laroche E.

Biochem J. 1994 Mar 15;298 Pt 3:629-33.

12.

Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence for glucose-dependent negative regulation.

Chantret I, Rodolosse A, Barbat A, Dussaulx E, Brot-Laroche E, Zweibaum A, Rousset M.

J Cell Sci. 1994 Jan;107 ( Pt 1):213-25.

13.

Expression and localization of GLUT-5 in Caco-2 cells, human small intestine, and colon.

Mahraoui L, Rousset M, Dussaulx E, Darmoul D, Zweibaum A, Brot-Laroche E.

Am J Physiol. 1992 Sep;263(3 Pt 1):G312-8.

PMID:
1384349
14.

Dihydrofolate reductase gene amplification-associated shift of differentiation in methotrexate-adapted HT-29 cells.

Lesuffleur T, Barbat A, Luccioni C, Beaumatin J, Clair M, Kornowski A, Dussaulx E, Dutrillaux B, Zweibaum A.

J Cell Biol. 1991 Dec;115(5):1409-18.

15.

Increased growth adaptability to 5-fluorouracil and methotrexate of HT-29 sub-populations selected for their commitment to differentiation.

Lesuffleur T, Kornowski A, Augeron C, Dussaulx E, Barbat A, Laboisse C, Zweibaum A.

Int J Cancer. 1991 Nov 11;49(5):731-7.

PMID:
1937959
16.

Adaptation to 5-fluorouracil of the heterogeneous human colon tumor cell line HT-29 results in the selection of cells committed to differentiation.

Lesuffleur T, Kornowski A, Luccioni C, Muleris M, Barbat A, Beaumatin J, Dussaulx E, Dutrillaux B, Zweibaum A.

Int J Cancer. 1991 Nov 11;49(5):721-30.

PMID:
1937958
18.

Monensin inhibits the expression of sucrase-isomaltase in Caco-2 cells at the mRNA level.

Chantret I, Trugnan G, Dussaulx E, Zweibaum A, Rousset M.

FEBS Lett. 1988 Aug 1;235(1-2):125-8.

19.
20.
21.

Enterocytic differentiation and glucose utilization in the human colon tumor cell line Caco-2: modulation by forskolin.

Rousset M, Laburthe M, Pinto M, Chevalier G, Rouyer-Fessard C, Dussaulx E, Trugnan G, Boige N, Brun JL, Zweibaum A.

J Cell Physiol. 1985 Jun;123(3):377-85.

PMID:
2985631
22.

The intracellular accumulation of UDP-N-acetylhexosamines is concomitant with the inability of human colon cancer cells to differentiate.

Wice BM, Trugnan G, Pinto M, Rousset M, Chevalier G, Dussaulx E, Lacroix B, Zweibaum A.

J Biol Chem. 1985 Jan 10;260(1):139-46.

23.

Enterocytic differentiation of a subpopulation of the human colon tumor cell line HT-29 selected for growth in sugar-free medium and its inhibition by glucose.

Zweibaum A, Pinto M, Chevalier G, Dussaulx E, Triadou N, Lacroix B, Haffen K, Brun JL, Rousset M.

J Cell Physiol. 1985 Jan;122(1):21-9.

PMID:
3880764
24.

Epithelial properties of human colonic carcinoma cell line Caco-2: electrical parameters.

Grasset E, Pinto M, Dussaulx E, Zweibaum A, Desjeux JF.

Am J Physiol. 1984 Sep;247(3 Pt 1):C260-7.

PMID:
6476109
25.

D-Glucosamine-induced increase of the glycerol-containing lipids in growing cultures of human malignant epithelial cells.

Krug E, Dussaulx E, Rozen R, Griglio S, de Gasquet P, Zweibaum A.

J Natl Cancer Inst. 1983 Jan;70(1):57-61.

PMID:
6571922
26.

Growth-related glycogen levels of human intestine carcinoma cell lines grown in vitro and in vivo in nude mice.

Rousset M, Dussaulx E, Chevalier G, Zweibaum A.

J Natl Cancer Inst. 1980 Nov;65(5):885-9.

PMID:
6933258
27.

Presence and cell growth-related variations of glycogen in human colorectal adenocarcinoma cell lines in culture.

Rousset M, Chevalier G, Rousset JP, Dussaulx E, Zweibaum A.

Cancer Res. 1979 Feb;39(2 Pt 1):531-4.

28.

Glycogen storage in foetal and malignant epithelial cells of the human colon.

Rousset M, Robine-Leon S, Dussaulx E, Chevalier G, Zweibaum A.

Front Gastrointest Res. 1979;4:80-5. No abstract available.

PMID:
428898
29.

Kinetics of glycogen levels in asynchronous and synchronous cultures of a human colon carcinoma cell line, HT 29.

Rousset M, Chevalier G, Rousset JP, Robine-Leon S, Dussaulx E, Zweibaum A.

Front Gastrointest Res. 1979;4:73-9. No abstract available.

PMID:
428897
30.

[Phenotypic expression of colon polymorphic antigens (WZ) in human colon adenocarcinomas].

Rousset M, Dussaulx E, Chevalier G, Zweibaum A.

C R Acad Hebd Seances Acad Sci D. 1978 Feb 27;286(8):659-62. French.

PMID:
97030
31.

Occurrence and kinetics of glycogen levels in the epidermal cells of grafted and cultured skin in mice.

Zweibaum A, Leon S, Rousset M, Dussaulx E, Chevalier G.

Transplantation. 1978 Jan;25(1):34-6. No abstract available.

PMID:
339446
32.
33.

Radioimmunoassay of the WZ polymorphic antigens of normal human colon and their relationship with ABH antigenic determinants.

Oriol R, Rousset M, Zweibaum A, Dalix AM, Chevalier G, Dussaulx E, Strecker G.

Immunology. 1977 Feb;32(2):131-7.

34.

[Polymorphic secretory antigens (WZ) of the human adult and fetal colon].

Zweibaum A, Rousset M, Oriol R, Dussaulx E, Chevalier G, Bondonnat P.

Ann Immunol (Paris). 1977 Jan-Mar;128(1-2):87-9. French.

PMID:
322592
35.

Determination of the structure of the immunodominant groups of the canine secretory alloantigens (CSA) by radioimmunoassay.

Oriol R, Strecker G, Rousset M, Chevalier G, Dalix AM, Dussaulx E, Zweibaum A.

Transplant Proc. 1975 Dec;7(4):523-8. No abstract available.

PMID:
1198701
36.

Purification, 125I labeling, and immunochemical study of the canine secretory alloantigens (CSA).

Rousset M, Oriol C, Zweibaum A, Chevalier G, Dalix AM, Dussaulx E, Oriol R.

Transplant Proc. 1975 Dec;7(4):519-22. No abstract available.

PMID:
1105913
37.

Correlation of canine secretory alloantigens A and Y with two fucolipids isolated from dog intestines.

Zweibaum A, Dussaulx E, Smith EL, McKibbin JM.

Proc Soc Exp Biol Med. 1974 Dec;147(3):883-6. No abstract available.

PMID:
4614273
38.

Studies on canine secretory alloantigens (CSA).

Zweibaum A, Oriol R, Feingold N, Dussaulx E, Rousset M, Chevalier G.

Tissue Antigens. 1974;4(2):115-29. No abstract available.

PMID:
4600070
39.

[Tissular distribution of the alloantigens of the secretory groups (digestive groups) in the dog].

Zweibaum A, Dussaulx E.

C R Acad Hebd Seances Acad Sci D. 1973 Jun 13;276(24):3237-9. French. No abstract available.

PMID:
4199022

Supplemental Content

Loading ...
Support Center